Statins, indication creep and risks for children and youth

MacDonald, Noni; Stanbrook, Matthew B.; Rieder, Michael J.
December 2008
CMAJ: Canadian Medical Association Journal;12/2/2008, Vol. 179 Issue 12, p1239
Academic Journal
The author reflects on the use of statins as a drug therapy for children and youth with hypercholesterolemia in the U.S. He argues that even if the American Academy of Pediatrics recommended the use of statins, there is a limited evidence that proves its efficacy. He also points out that the long-term safety and risk factors of the medicine should be definitely established. He proposes the implementation of assessment programs on the long-term use of statins and the use of alternative medicine.


Related Articles

  • FEEDBACK Letters to the Editor. Cruickshank, Alan; Thornes, Jon // Children & Young People Now;8/7/2012, p18 

    Two letters to the editor are presented in response to articles including the recommendations of the Children and Young People's Health Outcomes Forum in the July 27, 2012 issue and related to the consultation on the nursery milk scheme of Great Britain that was published in the previous issue.

  • Towards evidence based medicine for paediatricians. Phillips, Bob // Archives of Disease in Childhood;Jan2015, Vol. 100 Issue 1, p106 

    The article focuses on various evidence-based pediatrics involving proxy outcome, surrogate measure and process measure. Topics discussed include treatment based on proxy measure where one cannot measure exactly what is needed, focus on the measurement surrogate measure which exemplifies the...

  • Unintentional Discontinuation of Statins May Increase Mortality After Traumatic Brain Injury in Elderly Patients: A Preliminary Observation. Orlando, Alessandro; Bar-Or, David; Salottolo, Kristin; Levy, Andrew Stewart; Mains, Charles W.; Slone, Denetta S.; Offner, Patrick J. // Journal of Clinical Medicine Research;2013, Vol. 5 Issue 3, p168 

    Background: The abrupt discontinuation of statin therapy has been suggested as being deleterious to patient outcomes. Although pre-injury statin (PIS) therapy has been shown to have a protective effect in elderly trauma patients, no study has examined how this population is affected by its...

  • Statin prescribing in Northern Ireland and England pre and post introduction of the quality and outcomes framework. Ibrahim Alabbadi; Grainne Crealey; Kathryn Turner; Therese Rafferty; Lynn Keenan; Penny Murray; James McElnay // Pharmacy World & Science;Feb2010, Vol. 32 Issue 1, p43 

    Abstract   Objective The objective of this research was to examine differences in patterns of statin prescribing between Northern Ireland and England both before and after the introduction of the Quality and Outcomes Framework (QOF). Setting: Primary care practices in Northern Ireland and...

  • Aspirin and Statin Nonuse Associated With Early Biochemical Failure After Prostate Radiation Therapy. Kanani, Samir P. // Clinical Oncology Alert;7/1/2012, p51 

    In a large retrospective series, 2051 men with clinically localized prostate cancer received definitive radiation therapy (RT) alone. The rates of aspirin use and statin use were 36% and 34%, respectively. The primary endpoint was IBF (interval to biochemical failure) of < 18 months. With a...

  • Do Statins Prevent Parkinson's Disease?  // Primary Care Reports;Sep2013, Vol. 19 Issue 9, p1 

    The article discusses the tolerability, safety and adverse outcomes of statins use. It states that the study in Taiwan showed that continued use of lipophilic statins such as atorvastatin and simvastatin decreased Parkinson's disease incidence. It mentions that the use of statins was associated...

  • Statins and Parkinson's disease. Elliott, William T. // Primary Care Reports;Sep2013 Clinical Briefs, p1 

    The article focuses on the potential of statins to prevent Parkinson's disease (PD), despite several warnings from the U.S. Food and Drug Administration (FDA) regarding its adverse effects. It mentions a study from Taiwan which compared the risks of PD in patients taking statins from those who...

  • Reduced Glomerular Filtration Rate and Its Association with Clinical Outcome in Older Patients at Risk of Vascular Events: Secondary Analysis. Ford, Ian; Bezlyak, Vladimir; Stott, David J.; Sattar, Naveed; Packard, Chris J.; Perry, Ivan; Buckley, Brendan M.; Jukema, J. Wouter; De Craen, Anton J. M.; Westendorp, Rudi G. J.; Shepherd, James // PLoS Clinical Trials;Jan2009, Vol. 6 Issue 1, p0076 

    Background Reduced glomerular filtration rate (GFR) is associated with increased cardiovascular risk in young and middle aged individuals. Associations with cardiovascular disease and mortality in older people are less clearly established. We aimed to determine the predictive value of the GFR...

  • Pravastatin was not better than usual care in reducing all-cause mortality or CHD events. Evans, Arthur T.; Lucas, Brian P. // ACP Journal Club;Jul/Aug2003, Vol. 139 Issue 1, p10 

    Provides information on a study which assessed whether pravastatin is better than usual care in reducing all-cause mortality and coronary heart diseases. Main outcome measures; Results; Details of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics